Skip to content

GENEREX BIOTECHNOLOGY CORP

CIK 0001059784

← back to feed
Revenue (TTM)
$607.81K
+782.2% YoY Q3 Jun 2021
Net Income (TTM)
−$32.67M
−211.0% YoY Q3 Jun 2021
EPS Diluted (TTM)
−$0.44
−228.6% YoY Q3 Jun 2021
Gross Margin
48.9%
Q3 Jun 2021
Operating Margin
-5,368.1%
Q3 Jun 2021
Net Margin
-5,375.3%
Q3 Jun 2021
Free Cash Flow (TTM)
−$4.27M
Q3 Jun 2021
Cash
$1.68M
Q3 Jun 2021
Total Debt
$8.56M
Q3 Jun 2021
Shares Outstanding
118.45M sh
Q3 Jun 2021

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings